How biomarkers can improve pneumonia diagnosis and prognosis: procalcitonin and mid-regional-pro-adrenomedullin.
Spoto S, Legramante JM, Minieri M, Fogolari M, Terrinoni A, Valeriani E, Sebastiano C, Bernardini S, Ciccozzi M, Angeletti PS.
Biomark Med. 2020 May;14(7):549-562. doi: 10.2217/bmm-2019-0414. Epub 2020 May 28.
PMID:32462910
Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)-A prospective multicenter study.
Dähne T, Bauer W, Essig A, Schaaf B, Barten-Neiner G, Spinner CD, Pletz MW, Rohde G, Rupp J, Witzenrath M, Panning M; Members of the CAPNETZ study group.